HOME         WEBSITE         SUBSCRIBE           E-GREETINGS   
                               

Tuesday, August 10, 2010

In search of a cover

After clamping down on hospitals allegedly overcharging patients holding cashless mediclaim policies, insurers have started restoring such facilities selectively. Still, the incident highlights the need to be careful while selecting a health policy which offers cashless hospitalization. Currently, insurance companies and hospitals are attempting to standardize the rates charged by hospitals. 

In regular health insurance, the hospital issues a bill, which is settled by the patient, and the insurance company reimburses the amount later. In cashless mediclaim, patients can be hospitalised and treated without any cash payment. The insurance company pays the sum directly to the hospital. Hospitals which are part of the insurance company's preferred provider network are eligible to offer cashless hospitalisation facilities. 

Last month, four public sector insurers slashed the number hospitals which could treat cashless policy holders, saying many hospitals were overcharging patients holding cashless mediclaims. This led to many customers being turned away by the hospitals or asked to pay upfront before hospitalization. 

Insurance Regulatory and Development Authority (Irda) chairman J Hari Narayan recently confirmed what many patients already knew: that some hospitals overcharge cashless mediclaim holders with needless tests and procedures. Narayan quoted data from Irda's Insurance Information Bureau at a recent Ficci healthcare insurance conference which showed that while average charges for a medical procedure under the reimbursement category were Rs 25,000, these go up to Rs 33,000 in cashless schemes. "A regulatory mechanism needs to be in place to address the complaints of overcharging," he said. The regulator also said that an insurer who violates his contract with the policy holder can be fined up to Rs 5 lakh. 

Be that as it may, consumers will have to be careful in selecting a cashless mediclaim policy. Various policies are available, matching one's requirements and budget. One needs to first define his own requirements like critical illness, injuries from accidents, hospitalisation expenses or outpatient department (OPD) expenses and the level of insurance. Most insurers have family floater plans, which provide insurance cover for self, spouse and two children under a single policy. 

After selecting a suitable policy, it is important to read the fine print to spot what all remains undisclosed. One has to check details of the expenses which will be reimbursed like diagnostic and medication costs. 

In most cases, OPD expenses can be claimed only as a reimbursement and not on a cashless basis. For those looking to cover expenses beyond hospitalisation, some companies offer policies which take care of OPD and pregnancy-related expenses too. Most of these policies come with sub-limits. 

If you see value in an outpatient policy, check the list of exclusions and sub-limits applicable to the ones that are admissible. These policies cost more than a regular or a floater policy. You can also opt for a hospital cash policy, which provides daily hospital allowances, which are otherwise not part of hospital bills. 

After you purchase the policy, continue with the same insurer. Since there is no insurance portability in India, switching to another insurer would mean losing the no-claim bonus accumulated with the earlier insurer and cover on illnesses that have a four-year waiting period. Customers above 45 have to go through medical tests even if they have never made claims. While some insurers selectively waive the pre-existing disease clause, one needs to check all these facts before switching.A certified financial planner says unless there is a well-defined insurance portability mechanism, the customer has to be careful in switching insurers, especially if it is in the private sector. 

Earlier, all mediclaim policies covered hospitalization, with sub-limits for room charges, medicine and doctor's fees. The sub-limits prompted customers to be prudent while selecting rooms, doctors and other facilities during the hospitalization process. Trouble began when insurers removed sub-limits to lure more customers. As a result, customers started moving to high-end hospitals. 

Bajaj Allianz Life Insurance MD & CEO Kamesh Goyal notes that some hospitals have a twin billing system, which patients don't question as they are covered. "We don't realise the inappropriate health practices will hit customers in the long run," he adds. 

The sole purpose of buying a health policy is to meet any unexpected illness or accident-related expenses. As health-care expenses surge, one must look for a cover which provides a combination of packages that not only cover curative expenses but also preventive care.

Blog Archive

____________________________________________________________________________________________

Disclaimer - All investments in Mutual Funds and securities are subject to market risks and uncertainty of dividend distributions and the NAV of schemes may go up or down depending upon factors and forces affecting securities markets generally. The past performance of the schemes is not necessarily indicative of the future performance and may not necessarily provide a basis for comparison with other investments. Investors are advised to go through the respective offer documents before making any investment decisions. Prospective client(s) are advised to go through all comparable products in offer before taking any investment decisions. Mutual Funds and securities investments are subject to market risks and there is no assurance or guarantee that the objectives of the fund will be achieved. Information gathered & material used in this document is believed to be from reliable sources. Decisions based on the information provided on this newsletter/document are for your own account and risk.


In the preparation of the material contained in this document, Varun Vaid has used information that is publicly available, including information developed in-house. Some of the material used in the document may have been obtained from members/persons other than the Varun Vaid and which may have been made available to Varun Vaid. Information gathered & material used in this document is believed to be from reliable sources. Varun Vaid however does not warrant the accuracy, reasonableness and/or completeness of any information. For data reference to any third party in this material no such party will assume any liability for the same. Varun Vaid does not in any way through this material solicit any offer for purchase, sale or any financial transaction/commodities/products of any financial instrument dealt in this material. All recipients of this material should before dealing and or transacting in any of the products referred to in this material make their own investigation, seek appropriate professional advice.


Varun Vaid, shall not liable for any loss, damage of any nature, including but not limited to direct, indirect, punitive, special, exemplary, consequential, as also any loss of profit in any way arising from the use of this material in any manner. The recipient alone shall be fully responsible/are liable for any decision taken on the basis of this material. All recipients of this material should before dealing and/or transacting in any of the products referred to in this material make their own investigation, seek appropriate professional advice. The investments discussed in this material may not be suitable for all investors. Any person subscribing to or investigating in any product/financial instruments should do soon the basis of and after verifying the terms attached to such product/financial instrument. Financial products and instruments are subject to market risks and yields may fluctuate depending on various factors affecting capital/debt markets. Please note that past performance of the financial products and instruments does not necessarily indicate the future prospects and performance there of. Such past performance may or may not be sustained in future. Varun Vaid, including persons involved in the preparation or issuance of this material may; (a) from time to time, have long or short positions in, and buy or sell the securities mentioned herein or (b) be engaged in any other transaction involving such securities and earn brokerage or other compensation in the financial instruments/products/commodities discussed here in or act as advisor or lender / borrower in respect of such securities/financial instruments/products/commodities or have other potential conflict of interest with respect to any recommendation and related information and opinions. The said person may have acted upon and/or in a manner contradictory with the information contained here. No part of this material may be duplicated in whole or in part in any form and or redistributed without the prior written consent of Varun Vaid. This material is strictly confidential to the recipient and should not be reproduced or disseminated to anyone else.


Varun Vaid also does not take any responsibility for the contents of the advertisements published. Readers are advised to verify the contents on their own before acting there upon.


Published Credits goes to following sources & all the mentioned sources as footer below the published material- Bloomberg, Valueresearch Online, Capital Market, Navindia, Franklin Templeton, Kitco, SBI AMC, LIC AMC, JM Financial AMC, HDFC AMC, The Hindu, Business Line, Personal FN, Economic Times, Reuters, Outlook Money, Business Standard, Times of India etc.